𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype

✍ Scribed by Laura Roncuzzi; Irene Brognara; Stefania Cocchi; Wainer Zoli; Anna Gasperi-Campani

Book ID
114135307
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
176 KB
Volume
135
Category
Article
ISSN
0165-4608

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Loss of heterozygosity on chromosome 9 i
Loss of heterozygosity on chromosome 9 in human breast cancer: Association with clinical variables and genetic changes at other chromosome regions
✍ Gudny Eiriksdottir; Asgeir Sigurdsson; Jon Gunnlaugur Jonasson; Bjarni A. Agnars πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 French βš– 801 KB

Primary breast tumors were tested for loss of heterozygosity (LOH), on chromosome 9p with microsatellite markers restricted to a 28 cM region including the MTSl gene. LOH was found with at least I marker in 38% of the 20 I cases analyzed. A high frequency of deletions was detected at the 9p23-pZI re

Loss of heterozygosity at the TP53 gene:
Loss of heterozygosity at the TP53 gene: Independent occurrence from genetic instability events in node-negative breast cancer
✍ Sarab Lizard-Nacol; Jean-Marc Riedinger; GΓ©rard Lizard; Anne-Lise Glasser; Nolwe πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 84 KB πŸ‘ 2 views

TP53 abnormalities have been reported as an early event in the process of cellular transformation of human breast cancers, and involved in mammary-tumor evolution, from in situ to invasive disease. In this study, node-negative (N-) tumors were examined for TP53 allelic loss in relation to different

Loss of heterozygosity at chromosome 17p
Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer
✍ Evgeny N. Imyanitov; Oleg I. Chernitsa; Irina F. Nikiforova πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 French βš– 703 KB

## Abstract Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti‐oncogene alterations. Amplification of the HER‐2 oncogene was detected in 15 tumours (25%), c‐myc in 2 (3%) only and HER‐1 in none. Distribution of Hras‐1 oncogene a

Loss of heterozygosity analysis at the B
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer
✍ Ana Osorio; Miguel de la Hoya; Raquel RodrΓ­guez-LΓ³pez; Angel MartΓ­nez-RamΓ­rez; A πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 115 KB πŸ‘ 1 views

## Abstract The __BRCA1__ and __BRCA2__ genes are responsible for a high proportion of familial breast cancer; germline mutations in these genes confer a lifetime risk of about 70% for developing breast cancer. Most of the described deleterious mutations are small deletions or insertions that origi